- International Fees
International fees are typically 3.25 times the domestic tuition. Exact cost will be calculated upon completion of registration.
Course Overview
This six-module course will cover quantitative polymerase chain reaction (qPCR) amplification in the clinical setting. Early modules with cover nucleic acids from a clinical testing perspective and then focus will transition to reverse transcription (RT) qPCR for RNA viruses such as SARS-CoV-2 virus, causative agent of COVID-19. Correct interpretation of assay control results will be emphasized so that patient Cq results can be accurately interpreted and correct results reported.
Prerequisite(s)
- No prerequisites are required for this course.
Credits
1.0
- Not offered this term
- This course is not offered this term. Notify me to receive email notifications when the course opens for registration next term.
Learning Outcomes
Upon successful completion of this course, the student will be able to:
- describe how patient viral RNA samples are prepared and infection risks are mitigated
- describe strategies for minimizing DNA contamination risk in the PCR lab
- explain the principles of a multiplex RT-qPCR TaqMan assay
- interpret qPCR assay controls to prevent reporting potential false-negative/false-positive patient results
- correctly assess patient results referring to a lab's Interpretation and Reporting Job Aid
Effective as of Fall 2020
Programs and courses are subject to change without notice.